Jan. 4, 2016
RENO, NV, /PRNewswire/ – Silver State Trading, Nevada’s premier cultivator, manufacturer and distributor of medical-grade cannabis and associated products, signed an agreement to acquire the assets of CA-based Trokie™, and obtained exclusive global rights to Trokie’s patents and intellectual property. The Trokie™ is a pharmaceutical lozenge that allows for extremely rapid delivery of Medicinal Cannabis that is consistent, controllable and repeatable. In addition, Dr. Kenton Crowley, Pharm.D., FAARFM, the creator and founder of Trokie™, will join the Silver State Trading leadership team in the role of Director of Research and Product Development.
Dr. Crowley stated, “I designed the Trokie™ to enable cannabis patients to, ‘Medicate with Confidence.’ The Trokie™ is designed for optimal absorption through the buccal membranes of the mouth, thereby bypassing the first pass metabolism seen with edibles. Partnering with Silver State Trading will enable us to more quickly ramp distribution to patients in need. Trokie™ is a high-tech pharmaceutical delivery system, requires advanced technical skill and equipment, and Silver State Trading can support that production.”
Silver State Trading’s co-President and Co-CEO, Shane Johnson, M.D., shares, “The Trokie™ is as medical as one can get in terms of route of administration, and a perfect formulation for medical cannabis patients such as those with cancer who don’t want to smoke, and seek greater reliability than can be obtained with edibles. We are excited to have Dr. Crowley join our team, and intend to develop a series of new products leveraging Dr. Crowley’s formulation expertise. We are also working on pharmacokinetic studies so that we can report objectively the bioavailability of Trokie’s different products, something that only GW Pharmaceuticals has accomplished to date.”
“Trokie™ created growing dispensary coverage inside California, in addition to a direct-to-patient model more focused on data collection and research. We benefit from the associated learning’s and market traction. Our immediate intention is to expand market coverage in California, while introducing Trokie to the legal Dispensary Channel inside Nevada. As Dispensary Operators well know, what is on the label needs to be the dosage found in the package, which is a growing concern. Trokie effectively solves that issue and is a perfect fit for patients in need,” offered Silver State Trading co-President and co-CEO John Sutton.
At Trokie™ we have a mission of being the catalyst in the transformation of the medicinal cannabis industry. Trokie™ is bridging the gap between traditional medicine and medicinal cannabis by pharmaceutical dosing combined with a unique delivery system. The Trokie™ is designed to slowly dissolve between the upper cheek and gum, utilizing the buccal absorption delivery method. Buccal absorption is similar to sublingual in that the goal is to maximize oral absorption, bypassing the First Pass Effect of metabolism (metabolized by the liver) that occurs during digestion. By avoiding the GI tract and the liver, the Trokie™ delivers a quick onset of medicinal effects. For more information, visit www.trokie.com, or email us at firstname.lastname@example.org.
About Silver State Trading
Silver State Trading was founded by a dedicated team of medical professionals, entrepreneurs, law enforcement and experienced cannabis growers, together aligned around establishing a best-of-breed organization operating inside the Nevada regulatory framework, and providing medical-grade cannabis products to patients in need. Based in Sparks, NV, we operate out of a state-of-the-art 40,000 sq. ft. facility with indoor cultivation and infused-product manufacturing. With our proprietary breeding program and organic growing techniques, we grow and market medical grade strains and manufacture premium concentrates for registered patients across the State of Nevada. For more information, visit www.silverstatetrading.com, or email us at email@example.com.
(775) 335-2033 ext. 700
SOURCE: Silver State Trading
This article originally appeared on PR Newswire